IBDEI048 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1449,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,1450,0)
 ;;=R50.9^^3^41^60
 ;;^UTILITY(U,$J,358.3,1450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1450,1,3,0)
 ;;=3^Fever, unspecified
 ;;^UTILITY(U,$J,358.3,1450,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,1450,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,1451,0)
 ;;=R59.9^^3^41^57
 ;;^UTILITY(U,$J,358.3,1451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1451,1,3,0)
 ;;=3^Enlarged lymph nodes, unspecified
 ;;^UTILITY(U,$J,358.3,1451,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,1451,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,1452,0)
 ;;=R36.9^^3^41^106
 ;;^UTILITY(U,$J,358.3,1452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1452,1,3,0)
 ;;=3^Urethral discharge, unspecified
 ;;^UTILITY(U,$J,358.3,1452,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,1452,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,1453,0)
 ;;=R36.0^^3^41^105
 ;;^UTILITY(U,$J,358.3,1453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1453,1,3,0)
 ;;=3^Urethral discharge without blood
 ;;^UTILITY(U,$J,358.3,1453,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,1453,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,1454,0)
 ;;=R76.11^^3^41^82
 ;;^UTILITY(U,$J,358.3,1454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1454,1,3,0)
 ;;=3^Nonspecific reaction to skin test w/o active tuberculosis
 ;;^UTILITY(U,$J,358.3,1454,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,1454,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,1455,0)
 ;;=Z21.^^3^41^27
 ;;^UTILITY(U,$J,358.3,1455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1455,1,3,0)
 ;;=3^Asymptomatic human immunodeficiency virus infection status
 ;;^UTILITY(U,$J,358.3,1455,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,1455,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,1456,0)
 ;;=Z86.19^^3^41^88
 ;;^UTILITY(U,$J,358.3,1456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1456,1,3,0)
 ;;=3^Personal history of other infectious and parasitic diseases
 ;;^UTILITY(U,$J,358.3,1456,1,4,0)
 ;;=4^Z86.19
 ;;^UTILITY(U,$J,358.3,1456,2)
 ;;=^5063465
 ;;^UTILITY(U,$J,358.3,1457,0)
 ;;=B49.^^3^42^5
 ;;^UTILITY(U,$J,358.3,1457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1457,1,3,0)
 ;;=3^Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,1457,1,4,0)
 ;;=4^B49.
 ;;^UTILITY(U,$J,358.3,1457,2)
 ;;=^5000690
 ;;^UTILITY(U,$J,358.3,1458,0)
 ;;=J67.0^^3^42^3
 ;;^UTILITY(U,$J,358.3,1458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1458,1,3,0)
 ;;=3^Farmer's lung
 ;;^UTILITY(U,$J,358.3,1458,1,4,0)
 ;;=4^J67.0
 ;;^UTILITY(U,$J,358.3,1458,2)
 ;;=^44962
 ;;^UTILITY(U,$J,358.3,1459,0)
 ;;=J67.9^^3^42^4
 ;;^UTILITY(U,$J,358.3,1459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1459,1,3,0)
 ;;=3^Hypersensitivity pneumonitis due to unspecified organic dust
 ;;^UTILITY(U,$J,358.3,1459,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,1459,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,1460,0)
 ;;=J69.0^^3^42^6
 ;;^UTILITY(U,$J,358.3,1460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1460,1,3,0)
 ;;=3^Pneumonitis due to inhalation of food and vomit
 ;;^UTILITY(U,$J,358.3,1460,1,4,0)
 ;;=4^J69.0
 ;;^UTILITY(U,$J,358.3,1460,2)
 ;;=^5008288
 ;;^UTILITY(U,$J,358.3,1461,0)
 ;;=J86.0^^3^42^7
 ;;^UTILITY(U,$J,358.3,1461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1461,1,3,0)
 ;;=3^Pyothorax with fistula
 ;;^UTILITY(U,$J,358.3,1461,1,4,0)
 ;;=4^J86.0
 ;;^UTILITY(U,$J,358.3,1461,2)
 ;;=^5008308
 ;;^UTILITY(U,$J,358.3,1462,0)
 ;;=J86.9^^3^42^8
 ;;^UTILITY(U,$J,358.3,1462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1462,1,3,0)
 ;;=3^Pyothorax without fistula
 ;;^UTILITY(U,$J,358.3,1462,1,4,0)
 ;;=4^J86.9
 ;;^UTILITY(U,$J,358.3,1462,2)
 ;;=^5008309
 ;;^UTILITY(U,$J,358.3,1463,0)
 ;;=J85.2^^3^42^2
 ;;
 ;;$END ROU IBDEI048
